Deutsche Bank AG boosted its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 35.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,922,994 shares of the company's stock after buying an additional 1,816,865 shares during the period. Deutsche Bank AG owned about 0.85% of Colgate-Palmolive worth $629,369,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of CL. Barclays PLC lifted its position in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after buying an additional 2,132,747 shares during the period. Principal Financial Group Inc. boosted its stake in shares of Colgate-Palmolive by 4.9% in the 3rd quarter. Principal Financial Group Inc. now owns 997,147 shares of the company's stock valued at $103,514,000 after purchasing an additional 46,944 shares in the last quarter. Northcape Capital Pty Ltd grew its holdings in shares of Colgate-Palmolive by 4.9% in the 4th quarter. Northcape Capital Pty Ltd now owns 6,012 shares of the company's stock worth $547,000 after purchasing an additional 282 shares during the last quarter. Hilltop National Bank increased its position in shares of Colgate-Palmolive by 22.3% during the 4th quarter. Hilltop National Bank now owns 2,409 shares of the company's stock worth $219,000 after purchasing an additional 440 shares in the last quarter. Finally, Harbor Capital Advisors Inc. lifted its holdings in Colgate-Palmolive by 5.3% during the 4th quarter. Harbor Capital Advisors Inc. now owns 13,874 shares of the company's stock valued at $1,261,000 after purchasing an additional 702 shares during the last quarter. Institutional investors own 80.41% of the company's stock.
Colgate-Palmolive Trading Down 1.0 %
Shares of Colgate-Palmolive stock traded down $0.92 during trading on Friday, hitting $89.91. 3,846,241 shares of the company were exchanged, compared to its average volume of 4,631,100. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The firm has a market capitalization of $72.86 billion, a P/E ratio of 25.54, a price-to-earnings-growth ratio of 4.20 and a beta of 0.39. The firm's fifty day moving average price is $92.21 and its 200 day moving average price is $91.53. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business's quarterly revenue was down 3.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.86 earnings per share. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive announced that its board has approved a share buyback program on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 6.8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board of directors believes its stock is undervalued.
Colgate-Palmolive Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be issued a dividend of $0.52 per share. The ex-dividend date is Thursday, April 17th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a yield of 2.31%. Colgate-Palmolive's payout ratio is currently 58.76%.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the stock. Piper Sandler dropped their price objective on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a report on Monday, March 31st. Citigroup raised their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a report on Monday, April 28th. StockNews.com cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday. Raymond James reaffirmed an "outperform" rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, UBS Group increased their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of "Hold" and a consensus target price of $102.39.
Check Out Our Latest Stock Report on CL
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.